	普通股股本		日
AbbVie	USD 1.77B	1.75B	2025-06
Amgen	USD 540M	1000K	2026-03
Anika Therapeutics	USD 13.89M	532K	2025-12
Arrowhead Research	USD 137.39M	1.69M	2025-12
AstraZeneca	USD 1.55B	73K	2026-03
BioCryst Pharmaceuticals	USD 213.06M	2.54M	2025-12
Biogen	USD 146.7M	200K	2025-09
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Enanta Pharmaceuticals	USD 212K	1000	2023-12
Gilead Sciences	USD 1.24B	1000K	2026-03
GlaxoSmithKline	GBP 4.05B	20.6M	2026-03
Halozyme Therapeutics	USD 118.52M	741K	2026-03
Heron Therapeutics	USD 188.31M	4.99M	2025-12
Immunic	USD 120.38M	21.73M	2025-12
Incyte	USD 199.95M	1.49M	2026-03
Insmed	USD 216.52M	2.27M	2026-03
Ionis Pharmaceuticals	USD 165.9M	3.93M	2026-03
J&J	USD 2.41B	1.35M	2026-03
Karyopharm Therapeutics	USD 18.31M	18.3M	2025-12
Ligand Pharmaceuticals	USD 19.66M	19.64M	2025-09
Merck	USD 2.47B	12.72M	2025-12
Neurocrine Biosciences	USD 100.6M	500K	2026-03
Novartis	USD 1.91B	60K	2026-03
Novavax	USD 162.58M	106K	2025-12
Pfizer	USD 5.7B	13M	2026-03
PTC Therapeutics	USD 81.47M	1.54M	2025-12
Roche Holding	CHF 796.77M	1.15M	2026-06
Sarepta Therapeutics	USD 105.57M	607K	2026-03
Vertex Pharmaceuticals	USD 254.2M	200K	2026-03